This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Brand Names
- Rabavert
- Generic Name
- Rabies virus inactivated antigen, A
- DrugBank Accession Number
- DB10283
- Background
Rabies virus inactivated antigen, A is an inactivated virus vacine for the intramuscular injection. It is an active immunization against rabies that can be administered pre- or post-exposure to the rabies virus.
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Inactivated - Synonyms
- Rabies virus strain flury lep antigen (propiolactone inactivated)
- Rabies virus vaccine flury-lep strain
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prevention of Rabies •••••••••••• - Associated Therapies
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbatacept The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Abatacept. Adalimumab The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Adalimumab. Aldesleukin The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Aldesleukin. Alefacept The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Alefacept. Alemtuzumab The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Alemtuzumab. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image RabAvert Kit 2.5 [iU]/1mL Intramuscular A-S Medication Solutions 2016-12-19 Not applicable US 
RabAvert Kit 2.5 [iU]/1mL Intramuscular A-S Medication Solutions 2014-07-08 2020-03-31 US RabAvert Kit; Powder, for suspension 2.5 [iU]/1mL Intramuscular Bavarian Nordic A/S 1997-11-11 Not applicable US RabAvert Kit 2.5 [iU]/1mL Intramuscular GSK Vaccines GmbH 2014-07-08 2020-03-31 US RabAvert Kit 2.5 [iU]/1mL Intramuscular GlaxoSmithKline Biologicals SA 2016-12-19 2024-01-31 US
Categories
- ATC Codes
- J06AA06 — Rabies serum
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- FK894Q51YE
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Active Not Recruiting Not Available Adverse Reaction to Vaccine 1 somestatus stop reason just information to hide Not Available Completed Not Available Rabies 1 somestatus stop reason just information to hide Not Available Completed Basic Science Rabies Vaccination Reaction 1 somestatus stop reason just information to hide Not Available Completed Other Rabies 1 somestatus stop reason just information to hide Not Available Completed Prevention Efficacy of the New CPRV 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection Intradermal; Intramuscular 2.5 IU/0.5mL Kit Intramuscular 2.5 [iU]/1mL Kit; powder, for suspension Intramuscular 2.5 [iU]/1mL Injection, powder, lyophilized, for solution Intramuscular ≥ 2.5 IU Injection, powder, lyophilized, for solution Intramuscular 2.5 IU/ml Injection, powder, for solution Intramuscular 2.5 iu/mL Injection, powder, for solution Intramuscular 2.5 IU - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at November 30, 2015 21:24 / Updated at June 12, 2020 16:52